Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
| Status: | Archived |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2010 |
| End Date: | July 2011 |
A Phase 2, Randomized Study Evaluating the Safety and Efficacy of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® in Subjects With Glaucoma or Ocular Hypertension and Ocular Surface Disease
The purpose of this study is to compare:
- the effect of Catioprost® and Travatan Z® on the ocular surface disease (OSD) in
subjects with glaucoma or ocular hypertension and ocular surface disease.
- the intraocular pressure (IOP) lowering effect and safety of Catioprost® and Travatan
Z® in subjects with glaucoma or ocular hypertension and ocular surface disease.
We found this trial at
1
site
Click here to add this to my saved trials
